Nieuwsfeed
- Quote: Challenges
- FVIII at the crossroad of coagulation, bone and immune biology: emerging evidence of biological activities beyond hemostasis
- Seeding drug discovery: telomeric tankyrase as a pharmacological target for the pathophysiology of high-altitude hypoxia
- Renal cell carcinoma therapy: Current and new drug candidates
- RIVM meldt 5.323 nieuwe coronabesmettingen op zaterdag
- Weekend reads: Former dean sent herself threatening letters; what it costs to sue for defamation; what a highly cited paper is worth
- Weekend reads: Former dean sent herself threatening letters; what it costs to sue for defamation; what a highly cited paper is worth
- Covid-19 restrictions on family hospital visits persist, despite concern
- Red Team: denk nu al na over coronabeleid na zomervakantie
- TrialSite News Daily Digest
- Novartis reshuffles its wild cards; Tough sell for Biogen? Googling proteins; Ken Frazier's new gig; and more
- Pharma's latest moves & patient advocacy lessons from Aduhelm approval
- House E&C leaders grill FDA on inspection backlog
- FDA seeks new members for Patient Engagement Collaborative
- Coronavirus (COVID-19) Update: July 23, 2021
- Burning questions about the next phase of the pandemic; an expert's take on concern over breakthrough infections
- Nouryant garners negative CHMP opinion for Parkinson's disease
- What comes next in the battle against the HIV epidemic?
- Quarterly Inactive Ingredient Database (IID) Change Log
- RWD, RWE, and improved patient outcomes: From FDA's Mini-Sentinel to real-world examples
- Recon: US buys 200M more doses of Pfizer vaccine; European Commission opens in-depth investigation into Illumina's bid to acquire Grail
- FDA Issues Call for Patient Voices in Trials
- COVID-19 vaccine tracker
- Limburgse zorginstelling schat schade hoogwater op 42,5 miljoen euro
- Vaccin Moderna goedgekeurd voor tieners
- Google's DeepMind opens its protein database to science — potentially cracking drug R&D wide open
- NZa: tijd is rijp voor sectoroverstijgende betaaltitel
- Moderna establishes public health-focused charity; FDA approves AstraZeneca diabetes drug for pediatric use
- Model Organism Research | Protecting Wild Salmon | New Space Treaty
- 6.453 nieuwe positieve coronatesten, iets meer dan donderdag
- Three biotechs price hefty IPOs just before the weekend, while a fourth and a SPAC seek spots on Wall Street
- Kodiak turns down $125M payment from Baker Bros. deal, slashes royalty cap by 55%
- Breakthrough infections, the power of lobbying, & pharma’s cinematic villainy
- Last chance: Nominate a STAT Wunderkind by July 30
- EMA rejects FDA-approved Parkinson's drug, signs off on Moderna vaccine use in adolescents ahead of FDA
- Jim Wilson startup Passage Bio plugs in CFO, CMO; Tillman Gerngross nabs a COO familiar with Covid-19 fight at Pfizer as Adagio files for IPO
- First Generic Drug Approvals
- COVID-19 vaccine Spikevax approved for children aged 12 to 17 in EU, CHMP, 23/07/2021
- Expanding small-molecule target space to mRNA translation regulation
- Road to effective data curation for translational research
- Meander weer in gesprek met VGZ, opnamestop opgeheven
- Novartis to pay nearly $178M in lawsuit over BRAF drug — and will be on the hook for royalty
- Covid-19 roundup: Pfizer to supply US with 200M more vaccines as UK study finds higher antibodies in 8-10 week intervals
- Your weekly highlights from CLOSER's twitter feed
- Draft guideline on the summary of product characteristics for antiparasitic veterinary medicinal products - Revision 1
- 6 top drugmakers offer perspectives on FDA's new covariates in RCTs guidance
- The RW Daily: When a retraction notice leaves out important details. And "Why Bad Science Is Sometimes More Appealing Than Good Science."
- VWS geeft formele erkenning klinisch verloskundigen af
- Drie nieuwe Faces of Science
- Drie nieuwe Faces of Science